Tremelimumab plus Durvalumab Prior to Chemoradiotherapy in Unresectable Locally Advanced NSCLC, the Induction Trial

Smeenk, MM; van Diessen, JNA; Boellaard, TN; Hartemink, KJ; de Vries, JF; Badrising, SK; Wondergem, M; Wittenberg, R; Monkhorst, K; van den Heuvel, MM; Theelen, WSME

JOURNAL OF THORACIC ONCOLOGY, 2023; 18 (11): S157